Economic conditions and investment opportunities are increasingly diverging across countries, sectors and asset classes as the AI investment cycle gathers pace against a more complex global ...
IFM Investors may own a host of airports, but its staff will be passing through them less after a crackdown on overseas ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
BOSTON, Dec. 2, 2019 /PRNewswire/ -- IFM Therapeutics (IFM), a privately-held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, today ...
The investment is part of Delix's Series C financing. Delix is a UC Davis spinout developing non-hallucinogenic neuroplastogens, a new class of fast-acting medicines developed for depression and other ...
Artificial intelligence (AI) investment, energy security and geopolitical disruptions are expected to influence private market opportunities in 2027, as investors navigate subdued growth, persistent ...
BOSTON, March 13, 2024 /PRNewswire/ -- IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, ...
The new facility expands the footprint of manufacturing, research, and development for ifm process instruments in the United States to 90,000 square feet. MALVERN, Pa., July 24, 2025 (Newswire.com) - ...
IFM Investors infrastructure boss Kyle Mangini says Australia has led the world in building the asset class over the past three decades. Now he sees three areas of growth. Kyle Mangini, the global ...
Australian investment manager IFM Investors will wind down its domestic private equity unit in coming years, citing a lack of scale to make it commercially viable and a focus on other global ...
IFM Investors Pty is in talks to raise about 1.6 billion Swiss francs ($2 billion) in debt to back its acquisition of Swiss data center operator Green Group AG, people with knowledge of the matter ...
IFM's incubator, IFM Discovery, will focus on developing small molecule immunotherapies for inflammatory diseases and cancers, the first of which will be housed in a new subsidiary: IFM Quattro.